Future Medicine India - November 2021![Add to My Favorites Add to Favorites](/static/icons/filled.svg)
![](/static/icons/sharenew.svg)
Future Medicine India - November 2021![Add to My Favorites Add to Favorites](/static/icons/filled.svg)
![](/static/icons/sharenew.svg)
Go Unlimited with Magzter GOLD
Read {{magName}} along with {{magCount}}+ other magazines & newspapers with just one subscription View catalog
1 Month $9.99
1 Year$99.99 $49.99
$4/month
Subscribe only to Future Medicine India
Buy this issue $3.99
Subscription plans are currently unavailable for this magazine. If you are a Magzter GOLD user, you can read all the back issues with your subscription. If you are not a Magzter GOLD user, you can purchase the back issues and read them.
In this issue
Cover Story:
DEPRESSED INDIA--Heavy burden of mental health issues is the next big challenge for India
In Focus:
FALCON STUDY ON SSI PREVENTION
Expert Views:
COVID SPECIAL- The Compliment Behind Enemy Lines
Straight Talk:
Clevergene CEO Tony Jose
Is TB Losing Attention?
In sub-Saharan Africa and Elsewhere, We Need to Look Harder for TB
![Is TB Losing Attention?](https://reseuro.magzter.com/100x125/articles/23335/788919/B1Z-lujq71637730000193/crp_IS-TB-LOSING-ATTENTION.jpg)
3 mins
FALCON STUDY SUGGESTS CHANGE IN WHO GUIDELINES ON SSI PREVENTION
Use of alcoholic chlorhexidine skin preparation and triclosan coated sutures to prevent Surgical Site Infection showed no additional benefits
![FALCON STUDY SUGGESTS CHANGE IN WHO GUIDELINES ON SSI PREVENTION](https://reseuro.magzter.com/100x125/articles/23335/788919/3inmhLwL21637732993161/crp_FALCON-STUDY-SUGGESTS-CHANGE-IN-WHO-GUIDELINES-ON-SSI-PREVENTION.jpg)
2 mins
THE COMPLEMENT - BEHIND ENEMY LINES
Despite a plethora of scientific literature available on SARSCoV2, SARS-CoV and MERS-CoV, there are still uncertainties that impede identification of new therapies
![THE COMPLEMENT - BEHIND ENEMY LINES](https://reseuro.magzter.com/100x125/articles/23335/788919/TBQ_21ey41637731565872/crp_THE-COMPLEMENT-BEHIND-ENEMY-LINES.jpg)
4 mins
“WE WANT TO BE A LEADER IN GENETIC DIAGNOSTICS AS A DIFFERENTIATOR AND NOT AS A ME-TOO PLAYER”
TONY JOSE, Co-Founder and CEO of Bangalore- based genomics company Clevergene that claims unrivalled discovery-genomics and genetic diagnostics capabilities, had a personal reason to take a deep interest in genetics.
![“WE WANT TO BE A LEADER IN GENETIC DIAGNOSTICS AS A DIFFERENTIATOR AND NOT AS A ME-TOO PLAYER”](https://reseuro.magzter.com/100x125/articles/23335/788919/_cFzIhc2g1637730556791/crp_WE-WANT-TO-BE-A-LEADER-IN-GENETIC-DIAGNOSTICS-AS-A-DIFFERENTIATOR-AND-NOT-AS-A-ME-TOO-PLAYER.jpg)
7 mins
ROLE OF NUTRACEUTICALS IN MODERN HEALTHCARE
With the pandemic teaching us the importance of overall nutrition, people are getting more flexible toward nutraceuticals
![ROLE OF NUTRACEUTICALS IN MODERN HEALTHCARE](https://reseuro.magzter.com/100x125/articles/23335/788919/pp52E689n1637733677517/crp_ROLE-OF-NUTRACEUTICALS-IN-MODERN-HEALTHCARE.jpg)
5 mins
FDA clears Pfizer-BioNTech vaccine for children
US drug regulator Food and Drug Administration has authorized the Pfizer-BioNTech COVID-19 Vaccine for children between 5 to 11 years of age.
![FDA clears Pfizer-BioNTech vaccine for children](https://reseuro.magzter.com/100x125/articles/23335/788919/FNmKPbgbB1637734868584/crp_FDA-clears-Pfizer-BioNTech-vaccine-for-children.jpg)
1 min
YOUNG MINDS THE MOST AFFECTED
11,396 CHILDREN DIED BY SUICIDE IN 2020, AN 18 PERCENT INCREASE FROM 2019 AND 21 PERCENT JUMP FROM 2018
4 mins
Critical Use Of Tractography In Removal Of Brain Tumours
Among Indian surgeons, it is rare to find the skilful art of using Diffusion Tensor Imaging-Fiber Tractography (DTI-FT), a novel MRI technique, to locate the facial nerve on the surface of the brain tumour before surgery
![Critical Use Of Tractography In Removal Of Brain Tumours](https://reseuro.magzter.com/100x125/articles/23335/788919/sv1cjE8Yp1637731080807/crp_CRITICAL-USE-OF-TRACTOGRAPHY-IN-REMOVAL-OF-BRAIN-TUMOURS.jpg)
4 mins
Remogliflozin, vildagliptin, metformin FDC approved for Type 2 Diabetes in India
Mumbai-based drumaker Glenmark Pharmaceuticals received approval for its fixed dose combination (FDC) of remogliflozin (100 mg), vildagliptin (50 mg) and metformin (500/ 1000 mg from the Drug Controller General of India.
![Remogliflozin, vildagliptin, metformin FDC approved for Type 2 Diabetes in India](https://reseuro.magzter.com/100x125/articles/23335/788919/-jKrT-TJg1637735102316/crp_Remogliflozin-vildagliptin-metformin-FDC-approved-for-Type-2-Diabetes-in-India.jpg)
3 mins
DIGITAL THERAPEUTICS: CHANGING PARADIGMS IN DIABETES CARE
With the emergence of DTx programs, doctors and healthcare staffcan extend their care and monitor a patient remotely for faster recovery
![DIGITAL THERAPEUTICS: CHANGING PARADIGMS IN DIABETES CARE](https://reseuro.magzter.com/100x125/articles/23335/788919/Ao6lnpvw_1637732617319/crp_DIGITAL-THERAPEUTICS-CHANGING-PARADIGMS-IN-DIABETES-CARE.jpg)
3 mins
Future Medicine India Magazine Description:
Publisher: NextGen Science Media Pvt Ltd
Category: Health
Language: English
Frequency: Monthly
Future Medicine is a monthly medical science and news magazine, specially designed and developed for the medical fraternity of India. It empowers clinicians with the knowledge of latest breakthroughs in science, provides prompt updates on emerging medical and industry trends. It imparts timely news, views and analysis of tomorrow’s science, along with a discussion forum of medical science experts, who can predict and influence the future of healthcare.
Future Medicine’s multi-format approach allows new-age medical and life sciences professionals to browse through topics that most appeal to them, put forth in an easy-to-understand and interesting manner. The primary focus is on bridging the gap between medical researchers and clinicians. Future Medicine ushers a refreshing change in the manner of scientific information access within the field of medical science.
Cancel Anytime [ No Commitments ]
Digital Only